Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Evogene (EVGN) over the last 13 years, with Q2 2025 value amounting to -$988000.0.

  • Evogene's Cash from Investing Activities fell 13077.88% to -$988000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $7.3 million, marking a year-over-year increase of 28509.97%. This contributed to the annual value of $9.6 million for FY2024, which is 31203.17% up from last year.
  • Evogene's Cash from Investing Activities amounted to -$988000.0 in Q2 2025, which was down 13077.88% from -$2.4 million recorded in Q1 2025.
  • Over the past 5 years, Evogene's Cash from Investing Activities peaked at $12.0 million during Q1 2022, and registered a low of -$29.8 million during Q1 2021.
  • Its 5-year average for Cash from Investing Activities is $530555.6, with a median of $1.0 million in 2022.
  • As far as peak fluctuations go, Evogene's Cash from Investing Activities soared by 1666363.64% in 2023, and later crashed by 153486.84% in 2024.
  • Evogene's Cash from Investing Activities (Quarter) stood at $2.0 million in 2021, then tumbled by 122.26% to -$447000.0 in 2022, then crashed by 31.1% to -$586000.0 in 2023, then surged by 1594.54% to $8.8 million in 2024, then crashed by 111.28% to -$988000.0 in 2025.
  • Its last three reported values are -$988000.0 in Q2 2025, -$2.4 million for Q1 2025, and $8.8 million during Q4 2024.